# Abvc Biopharma, Inc.: Form 8-K/A, filed Jul 18, 2025

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: 8-K/A
- Filed: 2025-07-18
- Accepted by EDGAR: Jul 18, 2025, 17:04 ET
- Period: 2024-02-08
- Accession: 0001213900-25-065728
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390025065728/ea0249475-8ka_abvcbio.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390025065728/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390025065728/ea0249475-8ka_abvcbio.htm

Filed Jul 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-065728. Last ingested by Listed: Nov 2, 2026, 09:52 ET. No prices; not investment advice.